Journal profile · ONCOLOGY
Clinical Cancer Investigation Journal
ISSN 2278-0513
Clinical Cancer Investigation Journal: hybrid open access; 3 articles in 2025; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, Clinical Cancer Investigation Journal's largest topics are Head and Neck Cancer Studies, Metastasis and carcinoma case studies and Sarcoma Diagnosis and Treatment, together about 27.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Clinical Cancer Investigation Journal is a double-blind peer-reviewed publication dedicated to advancing the understanding and treatment of cancer through rigorous clinical research. Our journal provides a platform for the dissemination of high-quality, innovative studies spanning various aspects of cancer diagnosis, prognosis, therapy, and survivorship. We welcome the knowledge base of cancer biology, pathology, genetics, immunology, and therapeutic interventions. With a commitment to excellence and relevance in the field of oncology, our mission is to foster collaboration among researchers and clinicians worldwide, ultimately striving towards improved outcomes for cancer patients.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Ala-Eddin Al MoustafaPublisher website
Editorial board by country: 1 in mainland China (about 20%); most named Canada 2, Mainland China 1, Germany 1, Pakistan 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Head and Neck Cancer StudiesMedicine9.3%
- Metastasis and carcinoma case studiesMedicine9.2%
- Sarcoma Diagnosis and TreatmentMedicine9.2%
- Breast Lesions and CarcinomasMedicine6.8%
- Lymphoma Diagnosis and TreatmentMedicine5.5%
- Oral Health Pathology and TreatmentDentistry5.3%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.1%
- Ovarian cancer diagnosis and treatmentMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
Early warning / risk: Removed from ESCI for editorial reasons on 20 March 2024. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Indexing the journal's website claims
SCIEEmbaseCASPublisher website
Other: EBSCO, Index Copernicus, EBSCO Publishing's Electronic Databases, ABCD Journal Indexing
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 16OpenAlex ·
- i10-index
- 48OpenAlex ·
- 2-year mean citedness
- 2.33OpenAlex ·
- Share of gold OA articles
- 25.18%LetPub ·
Volume
- Articles per year
- 37LetPub ·
Articles by year OpenAlex count · 1,065 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 154 |
| 2025 | 3 | 3 | 215 |
| 2024 | 24 | 23 | 266 |
| 2023 | 60 | 59 | 369 |
| 2022 | 47 | 47 | 256 |
| 2021 | 64 | 40 | 276 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- ISSN
- 2278-0513
- Print ISSN
- 2278-1668
- Latest issue on the website
- Volume 14 (2025)
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Clinical Cancer Investigation Journal
Where are the editorial board members of Clinical Cancer Investigation Journal based?
Of the 5 board members whose country the journal's board page names, 1 (about 20%) are in mainland China; the countries named most often are Canada (2), Mainland China (1) and Germany (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Cancer Investigation Journal?
The journal's website lists SCIE, Embase and CAS; that list has not been checked against each database.
Is Clinical Cancer Investigation Journal open access, and what is the APC?
Clinical Cancer Investigation Journal is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .